Structure-Based Discovery of Novel Ligands for the Orexin 2 Receptor

被引:8
|
作者
Gunera, Jakub [1 ]
Baker, Jillian G. [2 ]
van Hilten, Niek [1 ]
Rosenbaum, Daniel M. [3 ,4 ]
Kolb, Peter [1 ]
机构
[1] Philipps Univ, Dept Pharmaceut Chem, D-35032 Marburg, Hesse, Germany
[2] Univ Nottingham, Queens Med Ctr, Cell Signalling, Sch Life Sci, Nottingham NG7 2UH, England
[3] UT Southwestern Med Ctr, Dept Biophys, Dallas, TX 75390 USA
[4] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA
关键词
BETA(2)-ADRENERGIC RECEPTOR; BINDING; DOCKING; ANTAGONIST;
D O I
10.1021/acs.jmedchem.0c00964
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The orexin receptors are peptide-sensing G protein-coupled receptors that are intimately linked with regulation of the sleep/wake cycle. We used a recently solved X-ray structure of the orexin receptor subtype 2 in computational docking calculations with the aim to identify additional ligands with unprecedented chemotypes. We found validated ligands with a high hit rate of 29% out of those tested, none of them showing selectivity with respect to the orexin receptor subtype 1. Furthermore, of the higher-affinity compounds examined, none showed any agonist activity. While novel chemical structures can thus be found, selectivity is a challenge owing to the largely identical binding pockets.
引用
收藏
页码:11045 / 11053
页数:9
相关论文
共 50 条
  • [21] Structure-guided discovery of orexin receptor-binding PET ligands
    Distler, Katharina
    Maschauer, Simone
    Neu, Eduard
    Huebner, Harald
    Einsiedel, Juergen
    Prante, Olaf
    Gmeiner, Peter
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 110
  • [22] Structure-Based Discovery of Novel Glycinergic Modulators
    Wells, Marta M.
    Reinert, Nathan
    Tang, Pei
    Xu, Yan
    BIOPHYSICAL JOURNAL, 2017, 112 (03) : 556A - 556A
  • [23] Structure-Based Discovery of Selective Serotonin 5-HT1B Receptor Ligands
    Rodriguez, David
    Brea, Jose
    Isabel Loza, Maria
    Carlsson, Jens
    STRUCTURE, 2014, 22 (08) : 1140 - 1151
  • [24] In search of novel ligands using a structure-based approach: a case study on the adenosine A2A receptor
    Lenselink, Eelke B.
    Beuming, Thijs
    van Veen, Corine
    Massink, Arnault
    Sherman, Woody
    van Vlijmen, Herman W. T.
    IJzerman, Adriaan P.
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2016, 30 (10) : 863 - 874
  • [25] In search of novel ligands using a structure-based approach: a case study on the adenosine A2A receptor
    Eelke B. Lenselink
    Thijs Beuming
    Corine van Veen
    Arnault Massink
    Woody Sherman
    Herman W. T. van Vlijmen
    Adriaan P. IJzerman
    Journal of Computer-Aided Molecular Design, 2016, 30 : 863 - 874
  • [26] Development of Novel PET Ligands for Imaging Orexin 2 Receptor
    Rong, Jian
    Yamasaki, Tomoteru
    Zhao, Chunyu
    Li, Yinlong
    Shao, Yihan
    Sun, Phillip
    Collier, Thomas
    Zhang, Ming-Rong
    Liang, Steven
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [27] Structure-based discovery of ligands targeted to the RNA double helix
    Chen, Q
    Shafer, RH
    Kuntz, ID
    BIOCHEMISTRY, 1997, 36 (38) : 11402 - 11407
  • [28] Discovery of novel human histamine H4 receptor ligands by large-scale structure-based virtual screening
    Kiss, Robert
    Kiss, Bela
    Koenczoel, Arpad
    Szalai, Ferenc
    Jelinek, Ivett
    Laszlo, Valeria
    Noszal, Bela
    Falus, Andras
    Keseru, Gyoergy M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (11) : 3145 - 3153
  • [29] Discovery of Novel Ligands for TNF-α and TNF Receptor-1 through Structure-Based Virtual Screening and Biological Assay
    Chen, Si
    Feng, Zhiwei
    Wang, Yun
    Ma, Shifan
    Hu, Ziheng
    Yang, Peng
    Chai, Yifeng
    Xie, Xiangqun
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2017, 57 (05) : 1101 - 1111
  • [30] Discovery of Novel α4β2 Neuronal Nicotinic Receptor Modulators through Structure-Based Virtual Screening
    Mahasenan, Kiran V.
    Pavlovicz, Ryan E.
    Henderson, Brandon J.
    Gonzalez-Cestari, Tatiana F.
    Yi, Bitna
    McKay, Dennis B.
    Li, Chenglong
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (11): : 855 - 860